Cargando…
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B(2) Receptor Antagonist
We here report the discovery and early characterization of Compound 3, a representative of a novel class of small molecule bradykinin (BK) B(2) receptor antagonists, and its superior profile to the prior art B(2) receptor antagonists Compound 1 and Compound 2. Compound 3, Compound 2, and Compound 1...
Autores principales: | Lesage, Anne, Gibson, Christoph, Marceau, François, Ambrosi, Horst-Dieter, Saupe, Jörn, Katzer, Werner, Loenders, Brigitte, Charest-Morin, Xavier, Knolle, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316994/ https://www.ncbi.nlm.nih.gov/pubmed/32636746 http://dx.doi.org/10.3389/fphar.2020.00916 |
Ejemplares similares
-
D-Arg(0)-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B(2) Receptor Agonist Metabolically Activated by Carboxypeptidases
por: Bachelard, Hélène, et al.
Publicado: (2018) -
Biotechnological Fluorescent Ligands of the Bradykinin B(1) Receptor: Protein Ligands for a Peptide Receptor
por: Charest-Morin, Xavier, et al.
Publicado: (2016) -
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B(2) receptor and peptidase resistance in rats
por: Charest-Morin, Xavier, et al.
Publicado: (2017) -
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B(2) receptor agonists
por: Charest-Morin, Xavier, et al.
Publicado: (2014) -
Pharmacological effects of recombinant human tissue kallikrein on bradykinin B(2) receptors
por: Charest-Morin, Xavier, et al.
Publicado: (2015)